Croda Atlas Point
✅ Low Risk
FEI: 2517099 • New Castle, DE • UNITED STATES
FEI Number
2517099
Location
New Castle, DE
Country
UNITED STATESAddress
315 Cherry Ln, , New Castle, DE, United States
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/5/2011 | 53PF99OTHER COSMETIC RAW MATERIALS, N.E.C. | 473LABELING | Los Angeles District Office (LOS-DO) |
Frequently Asked Questions
What is Croda Atlas Point's FDA import refusal history?
Croda Atlas Point (FEI: 2517099) has 1 FDA import refusal record(s) in our database, spanning from 4/5/2011 to 4/5/2011.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Croda Atlas Point's FEI number is 2517099.
What types of violations has Croda Atlas Point received?
Croda Atlas Point has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Croda Atlas Point come from?
All FDA import refusal data for Croda Atlas Point is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.